Title: Specialized CRO Indero Standardizes on Veeva RTSM for Enhanced Clinical Trial Operations

Indero, a specialized Contract Research Organization (CRO), has recently adopted Veeva RTSM to drive operational efficiency and accelerate study timelines. This strategic partnership has allowed Indero to streamline its clinical trial operations, harnessing advanced RTSM capabilities to enhance process consistency and execution.

The collaboration between Indero and Veeva Systems has resulted in the successful launch of Indero’s 40th RTSM study, marking a milestone in their ongoing partnership. By standardizing with Veeva RTSM, Indero has been able to optimize its clinical trial processes, ensuring seamless execution and faster delivery of therapies to market.

Eric Hardy, senior director of biometrics at Indero, highlights the benefits of Veeva RTSM in driving efficiency and effectiveness in clinical trial operations. This standardized approach has enabled Indero to work closely with Veeva to refine and implement processes that ensure long-term success in their studies.

Steve Simmerman, general manager of Veeva RTSM, emphasizes the importance of standardizing clinical processes to achieve greater efficiency and reliability. The partnership between Indero and Veeva is paving the way for accelerated study timelines and industry advancements.

In conclusion, the collaboration between Indero and Veeva Systems showcases the power of standardized processes in driving operational efficiency and faster study timelines. By leveraging Veeva RTSM, Indero has been able to enhance its clinical trial operations and bring therapies to market more efficiently. This partnership exemplifies the benefits of strategic alliances in advancing the life sciences industry.